NRC Health (NRC) vs Phreesia (PHR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NRC Health (NRC) has outperformed Phreesia (PHR) over the past year, gaining 68.0% versus a loss of 54.2%. Over five years, NRC leads with a -52.9% price change compared with -83.5% for PHR. Phreesia is the larger company by market cap ($661.7 million vs $451.7 million), about 1.5 times the size.
On valuation, Phreesia trades at a lower forward P/E (6.7x vs 19.4x for NRC Health). NRC Health pays a dividend yielding 2.94%, while Phreesia does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NRC | PHR |
|---|---|---|
| Share price | $20.42 | $10.66 |
| Market cap | $451.68M | $661.68M |
| 1-day change | +1.14% | +1.52% |
| YTD return | +7.57% | -37.00% |
| 1-year return | +67.97% | -54.15% |
| 5-year return | -52.92% | -83.51% |
| P/E ratio (TTM) | 85.08 | 62.71 |
| Forward P/E | 19.45 | 6.74 |
| EPS (TTM) | $0.24 | $0.17 |
| Dividend yield | 2.94% | 0.00% |
| Annual dividend | $0.60 | $0.00 |
| 52-week high | $23.68 | $24.25 |
| 52-week low | $11.01 | $7.77 |
| Distance from 52-week high | -13.77% | -56.03% |
| Analyst consensus | none | buy |
| Avg. price target upside | +27.33% | +31.99% |
| Average volume | 115.35K | 741.28K |
| Shares outstanding | 22.12M | 62.07M |
| Employees | 357 | 1,789 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRC has outperformed PHR by 122.1 percentage points over the past year.
- NRC Health trades at a higher earnings multiple (85.1x vs 62.7x trailing P/E).
- NRC Health offers a meaningfully higher dividend yield (2.94% vs 0.00%).
- The two companies sit in different sectors: NRC Health in Health Care and Phreesia in Consumer Discretionary.
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
About Phreesia
PHR stock →Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Consumer Discretionary · Business Services · 1,789 employees
NRC vs PHR FAQ
Which is bigger, NRC Health or Phreesia?
Phreesia (PHR) is larger, with a market capitalization of $661.68M compared with $451.68M for NRC Health (NRC).
Which stock has performed better over the past year, NRC or PHR?
NRC returned +67.97% over the past 12 months, compared with -54.15% for PHR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NRC or PHR?
PHR has the lower trailing P/E at 62.7, versus 85.1 for NRC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, NRC Health or Phreesia?
NRC Health pays a dividend yielding 2.94%, while Phreesia does not currently pay a regular dividend.
Are NRC Health and Phreesia in the same industry?
No. NRC Health is in the Health Care sector, while Phreesia is in Consumer Discretionary.